Venrock Adviser, LLC
Net seller this quarter
$3.3B
33
-$249M
80.4%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
| APGE | $1.13B | 34.18% | 11.27% | Not reported | Q3 2023 |
 ORKA | $395M | 11.97% | 6.79% | Not reported | Q3 2024 |
 ERAS | $328M | 9.94% | 5.72% | +9.2% | Q2 2024 |
 SYRE | $265M | 8.04% | 3.39% | -19.0% | Q4 2023 |
 DNTH | $115M | 3.49% | 2.15% | Not reported | Q3 2023 |
 OCUL | $102M | 3.08% | 4.71% | Not reported | Q4 2023 |
 DMRA | $93.7M | 2.84% | 5.84% | Not reported | Q1 2026 |
 SVRA | $90.8M | 2.75% | 7.18% | +7.3% | Q1 2022 |
 JBIO | $71.6M | 2.17% | 5.07% | Not reported | Q2 2025 |
 COGT | $63.6M | 1.93% | 0.96% | -17.9% | Q4 2020 |
 VRDN | $59.8M | 1.81% | 2.88% | -16.1% | Q4 2020 |
 VOR | $56M | 1.70% | 5.59% | Not reported | Q3 2025 |
 DYN | $48.3M | 1.46% | 1.31% | Not reported | Q2 2023 |
 MAZE | $47.8M | 1.45% | 2.89% | Not reported | Q3 2025 |
 RLMD | $47.4M | 1.44% | 6.42% | +41.3% | Q1 2020 |
 ORIC | $46.8M | 1.42% | 4.17% | Not reported | Q2 2023 |
 CBIO | $38.4M | 1.16% | 7.69% | Not reported | Q2 2025 |
 ZURA | $38M | 1.15% | 6.74% | Not reported | Q2 2024 |
 ANL | $36.9M | 1.12% | Not reported | Not reported | Q1 2026 |
 ELVN | $26.7M | 0.81% | 0.72% | -69.5% | Q1 2023 |
 HELP | $25.5M | 0.77% | 7.46% | Not reported | Q4 2025 |
 CGEM | $25.1M | 0.76% | 2.14% | Not reported | Q1 2021 |
 IPSC | $21.3M | 0.65% | 4.82% | Not reported | Q1 2024 |
 ARTV | $19.8M | 0.60% | 8.27% | +27.0% | Q3 2024 |
 CTMX | $18.7M | 0.57% | 2.29% | -50.1% | Q2 2025 |
 ACHV | $18M | 0.54% | 2.68% | New | Q2 2026 |
 PBLS | $17.1M | 0.52% | 0.51% | New | Q2 2026 |
 SRZN | $16.4M | 0.50% | 5.38% | Not reported | Q1 2025 |
 KRRO | $13.3M | 0.40% | 6.86% | Not reported | Q1 2026 |
 ANRO | $13.2M | 0.40% | 1.42% | Not reported | Q1 2026 |
 XFOR | $9.03M | 0.27% | 2.01% | +485.2% | Q1 2026 |
 RACC | $3.21M | 0.10% | Not reported | New | Q2 2026 |
 INM | $50.7K | 0.00% | 0.61% | New | Q2 2026 |
| Q1 2026 | |||||
| APGE | $715M | 26.68% | 11.34% | Not reported | Q3 2023 |
| ERAS | $265M | 9.89% | 5.27% | -8.3% | Q2 2024 |
| ORKA | $203M | 7.60% | 8.27% | Not reported | Q3 2024 |
| SYRE | $186M | 6.94% | 4.67% | Not reported | Q4 2023 |
| KALV | $130M | 4.86% | 12.64% | -3.8% | Q4 2022 |
| DNTH | $99M | 3.70% | 2.16% | +18.0% | Q3 2023 |
| DMRA | $93.3M | 3.48% | 5.98% | New | Q1 2026 |
| OCUL | $87.6M | 3.27% | 4.73% | +41.4% | Q4 2023 |
| COGT | $77M | 2.87% | 1.17% | Not reported | Q4 2020 |
| VRDN | $75.9M | 2.83% | 3.79% | Not reported | Q4 2020 |
| SVRA | $75M | 2.80% | 6.71% | Not reported | Q1 2022 |
| ELVN | $67.7M | 2.53% | 2.84% | -46.5% | Q1 2023 |
| ORIC | $54.7M | 2.04% | 4.17% | -23.9% | Q2 2023 |
| VOR | $54.3M | 2.03% | 5.61% | +56.5% | Q3 2025 |
| MAZE | $47.8M | 1.78% | 3.22% | +3.5% | Q3 2025 |
| CTMX | $46.9M | 1.75% | 5.87% | -35.9% | Q2 2025 |
| JBIO | $45.2M | 1.69% | 6.53% | Not reported | Q2 2025 |
| DYN | $39.4M | 1.47% | 1.32% | Not reported | Q2 2023 |
| CBIO | $39.2M | 1.46% | 7.74% | Not reported | Q2 2025 |
| ZURA | $38.3M | 1.43% | 6.78% | +20.4% | Q2 2024 |
| RLMD | $33.7M | 1.26% | 4.62% | Not reported | Q1 2020 |
 ENGN | $32.5M | 1.21% | 7.12% | Not reported | Q1 2024 |
 TENX | $26.8M | 1.00% | 6.90% | Not reported | Q3 2024 |
| ANL | $22.2M | 0.83% | Not reported | New | Q1 2026 |
| IPSC | $19.7M | 0.73% | 4.83% | Not reported | Q1 2024 |
| CGEM | $19.6M | 0.73% | 2.25% | Not reported | Q1 2021 |
| HELP | $18.5M | 0.69% | 7.46% | +0.3% | Q4 2025 |
| SRZN | $18.4M | 0.69% | 5.51% | Not reported | Q1 2025 |
 SEPN | $12.2M | 0.45% | 1.13% | -17.2% | Q2 2025 |
| KRRO | $11.4M | 0.43% | 7.00% | New | Q1 2026 |
| ANRO | $11.2M | 0.42% | 1.43% | New | Q1 2026 |
| ARTV | $10.4M | 0.39% | 6.51% | Not reported | Q3 2024 |
| XFOR | $1.37M | 0.05% | 0.35% | New | Q1 2026 |
| Q4 2025 | |||||
| APGE | $641M | 31.67% | 12.42% | Not reported | Q3 2023 |
| ORKA | $126M | 6.21% | 8.51% | Not reported | Q3 2024 |
| VRDN | $121M | 5.97% | 3.81% | Not reported | Q4 2020 |
| SYRE | $121M | 5.96% | 4.71% | +37.2% | Q4 2023 |
| KALV | $109M | 5.37% | 13.22% | Not reported | Q4 2022 |
| OCUL | $88.8M | 4.39% | 3.39% | -44.4% | Q4 2023 |
| SVRA | $82.9M | 4.09% | 6.72% | +8.4% | Q1 2022 |
| COGT | $71M | 3.51% | 1.24% | -50.0% | Q4 2020 |
| ERAS | $66.4M | 3.28% | 6.28% | Not reported | Q2 2024 |
| CTMX | $66.3M | 3.27% | 9.14% | Not reported | Q2 2025 |
| MAZE | $64.2M | 3.17% | 3.14% | +25.8% | Q3 2025 |
| JBIO | $49.7M | 2.45% | 6.53% | Not reported | Q2 2025 |
| ELVN | $49.7M | 2.45% | 5.43% | Not reported | Q1 2023 |
| ORIC | $46.4M | 2.29% | 5.76% | -14.0% | Q2 2023 |
| ENGN | $43.1M | 2.13% | 7.12% | -5.5% | Q1 2024 |
| DYN | $42.5M | 2.10% | 1.32% | Not reported | Q2 2023 |
| DNTH | $41.2M | 2.04% | 2.31% | +4.1% | Q3 2023 |
 UPB | $31.7M | 1.57% | 2.16% | Not reported | Q4 2024 |
| HELP | $31.4M | 1.55% | 17.78% | New | Q4 2025 |
| ZURA | $28M | 1.38% | 7.25% | +15.4% | Q2 2024 |
| VOR | $25.4M | 1.26% | 5.02% | +288.8% | Q3 2025 |
| CBIO | $25.3M | 1.25% | 7.74% | +53.7% | Q2 2025 |
| SEPN | $17M | 0.84% | 1.36% | Not reported | Q2 2025 |
| SRZN | $14.3M | 0.71% | 6.48% | Not reported | Q1 2025 |
| CGEM | $14.3M | 0.71% | 2.29% | Not reported | Q1 2021 |
| ARTV | $6.91M | 0.34% | 6.56% | Not reported | Q3 2024 |
| CASIF | $839K | 0.04% | 4.80% | Not reported | Q2 2024 |
| Q3 2025 | |||||
| APGE | $337M | 18.99% | 14.32% | Not reported | Q3 2023 |
| MTSR | $196M | 11.05% | 3.57% | Not reported | Q1 2025 |
| OCUL | $154M | 8.66% | 7.52% | +3.1% | Q4 2023 |
| CDTX | $90.7M | 5.10% | 3.23% | +48.2% | Q4 2024 |
| VRDN | $83.8M | 4.72% | 4.72% | Not reported | Q4 2020 |
| KALV | $82M | 4.61% | 13.31% | Not reported | Q4 2022 |
| ORKA | $79.8M | 4.49% | 8.57% | Not reported | Q3 2024 |
| ORIC | $79.2M | 4.46% | 6.78% | Not reported | Q2 2023 |
| ELVN | $66M | 3.72% | 5.44% | -19.9% | Q1 2023 |
| COGT | $57.4M | 3.23% | 2.86% | -15.9% | Q4 2020 |
| CTMX | $49.6M | 2.79% | 9.44% | +11.4% | Q2 2025 |
 ABVX | $49M | 2.76% | 0.91% | -57.2% | Q4 2023 |
| SVRA | $45.3M | 2.55% | 7.34% | +42.7% | Q1 2022 |
| SYRE | $45M | 2.53% | 4.44% | Not reported | Q4 2023 |
| ERAS | $38.9M | 2.19% | 6.29% | Not reported | Q2 2024 |
| DNTH | $37.8M | 2.13% | 2.24% | -3.9% | Q3 2023 |
| ENGN | $34.5M | 1.94% | 9.86% | Not reported | Q1 2024 |
| MAZE | $31.9M | 1.80% | 2.56% | New | Q3 2025 |
| JBIO | $27.8M | 1.56% | 9.87% | Not reported | Q2 2025 |
| DYN | $27.5M | 1.55% | 1.52% | Not reported | Q2 2023 |
| VOR | $24.4M | 1.37% | 5.54% | New | Q3 2025 |
| UPB | $22M | 1.24% | 2.17% | -49.1% | Q4 2024 |
| ZURA | $20.1M | 1.13% | 7.12% | Not reported | Q2 2024 |
| ATXS | $17.9M | 1.01% | 4.35% | Not reported | Q3 2021 |
 PHVS | $16.8M | 0.95% | 1.24% | -67.1% | Q1 2021 |
| CBIO | $16.5M | 0.93% | 9.99% | Not reported | Q2 2025 |
| SEPN | $11.5M | 0.65% | 1.37% | +13.0% | Q2 2025 |
| CGEM | $8.18M | 0.46% | 2.34% | Not reported | Q1 2021 |
| SRZN | $8.16M | 0.46% | 7.38% | Not reported | Q1 2025 |
 FRNM | $7.95M | 0.45% | 8.42% | Not reported | Q2 2024 |
| ARTV | $4.62M | 0.26% | 6.59% | Not reported | Q3 2024 |
| TENX | $3.33M | 0.19% | 7.41% | +344.1% | Q3 2024 |
| CASIF | $1.64M | 0.09% | 6.37% | Not reported | Q2 2024 |